Biotech Investors & VC Firms

2107 firms in this list, with a median first check of $500K. 405 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
PA Panakes Partners ABDSFLBC11 people · Follows rounds	88🔒	Milan	IT	Seed–Late Stage	—	+ Add to CRM
SI Sirius Venture Partners GmbH FVMBASJS8 people	88🔒	Wiesbaden	DE	Seed–Growth	$540K – $5.4M	+ Add to CRM
SY Syridex Bio SSVPJACW11 people	88🔒	Princeton	US	Pre-Seed–Late Stage	—	+ Add to CRM
TE tecnet equity NÖ Technologiebeteiligungs-Invest GmbH DACLJMRD8 people	88🔒	St. Pölten	AT	Seed–Series A	$324K – $3.2M	+ Add to CRM
TE TeleVenture Management AS RRDTJARS11 people	88🔒	Oslo	NO	Seed–Series A	—	+ Add to CRM
YZ YZR Capital MFRMHEMS11 people	88🔒	Munich	DE	Pre-Seed–Growth	—	+ Add to CRM
CP CP Ventures ESCS2 people · Leads rounds	88🔒	North Sydney	AU	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
H H Venture Partners EEBB2 people · Follows rounds	88🔒	Cincinnati	US	Seed–Late Stage	$250K – $5M	+ Add to CRM
NO Noetic SSWW2 people	88🔒	Toronto, Ontario	CA	Seed–Series A	—	+ Add to CRM
PR Propagator Ventures AFAEETAA7 people	88🔒	Oslo	NO	Pre-Seed–Series A	—	+ Add to CRM
IN iNetworks ALAJMDGM9 people	88🔒	Pittsburgh	US	Seed–Late Stage	—	+ Add to CRM
KI KIC Ventures KRAHVLAW9 people	88🔒	Fort Lauderdale	US	Seed–Late Stage	—	+ Add to CRM
MI Militia Hill Ventures JHJLBDS9 people	88🔒	Philadelphia	US	Seed–Series A	—	+ Add to CRM
PA Pathway Bioventures DJMMJSDH5 people	88🔒	Chicago	US	Pre-Seed–Series A	—	+ Add to CRM
SC Scientific Health Development AOPRSFMS5 people	88🔒	Dallas	US	Pre-Seed–Series A	$2M	+ Add to CRM
AC Access Biotechnology LRCB2 people · Leads rounds	88🔒	New York City	US	Seed–Late Stage	—	+ Add to CRM
ZÜ Zühlke Ventures PGSW2 people · Follows rounds	88🔒	Zurich	CH	Pre-Seed–Series A	$165K – $275K	+ Add to CRM
BL Bluegrass Angel Venture JN1 person · Leads rounds	88🔒	Lexington	US	Pre-Seed–Seed	—	+ Add to CRM
B3 B3 Holding PBPBPBMŠ4 people	88🔒	Prague	CZ	—	—	+ Add to CRM
BR Bridge to Growth GGMBSSFW4 people	88🔒	Berlin	DE	Series A–Late Stage	$1.1M – $5.4M	+ Add to CRM
DE Development Capital ABSHACFS7 people	88🔒	Dublin	IE	Growth	$2.2M – $13.2M	+ Add to CRM
OP OphthaFund GMTMAMJT7 people · Leads rounds	88🔒	Charleston	US	Pre-Seed–Series A	—	+ Add to CRM
RT RTW Investments L.P. NYGMJKLC16 people	88🔒	New York	US	Seed–Series A	—	+ Add to CRM
TR Triatomic Capital JHPZSHWV6 people · Leads rounds	88🔒	Palo Alto	US	Seed–Series C	$100K – $1M	+ Add to CRM

Panakes Partners

MilanSeed–Late Stage

ABDSFLBC11 people

Sirius Venture Partners GmbH

WiesbadenSeed–Growth$540K – $5.4M

FVMBASJS8 people

Syridex Bio

PrincetonPre-Seed–Late Stage

SSVPJACW11 people

tecnet equity NÖ Technologiebeteiligungs-Invest GmbH

St. PöltenSeed–Series A$324K – $3.2M

DACLJMRD8 people

TeleVenture Management AS

OsloSeed–Series A

RRDTJARS11 people

YZR Capital

MunichPre-Seed–Growth

MFRMHEMS11 people

CP Ventures

North SydneyPre-Seed–Series A$100K – $500K

ESCS2 people

H Venture Partners

CincinnatiSeed–Late Stage$250K – $5M

EEBB2 people

Noetic

Toronto, OntarioSeed–Series A

SSWW2 people

Propagator Ventures

OsloPre-Seed–Series A

AFAEETAA7 people

iNetworks

PittsburghSeed–Late Stage

ALAJMDGM9 people

KIC Ventures

Fort LauderdaleSeed–Late Stage

KRAHVLAW9 people

Militia Hill Ventures

PhiladelphiaSeed–Series A

JHJLBDS9 people

Pathway Bioventures

ChicagoPre-Seed–Series A

DJMMJSDH5 people

Scientific Health Development

DallasPre-Seed–Series A$2M

AOPRSFMS5 people

Access Biotechnology

New York CitySeed–Late Stage

LRCB2 people

Zühlke Ventures

ZurichPre-Seed–Series A$165K – $275K

PGSW2 people

Bluegrass Angel Venture

LexingtonPre-Seed–Seed

JN1 person

B3 Holding

Prague

PBPBPBMŠ4 people

Bridge to Growth

BerlinSeries A–Late Stage$1.1M – $5.4M

GGMBSSFW4 people

Development Capital

DublinGrowth$2.2M – $13.2M

ABSHACFS7 people

OphthaFund

CharlestonPre-Seed–Series A

GMTMAMJT7 people

RTW Investments L.P.

New YorkSeed–Series A

NYGMJKLC16 people

Triatomic Capital

Palo AltoSeed–Series C$100K – $1M

JHPZSHWV6 people

Data sourced from public filings and firms' own websites — see our methodology.